IRONWOOD PHARMACEUTICALS INC
IRWDReported to SECin USCIK 0001446847Filings at SEC EDGAR
No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.
This page is free to read, and it stops after 3 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.
Filings
Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.
| Filed by | Type | Value | Reported | Filed by | Value | Type | Shares | Reported |
|---|---|---|---|---|---|---|---|---|
| DENNER ALEXANDER J— | Award | nothing paid3,694 shares | Sep 17, 2026 | DENNER ALEXANDER J | nothing paid | Award | 3,694 | Sep 17, 2026 |
| Silber JeffreySVP, CMO, Head-Res&Drug | Award | nothing paid137,036 shares | Jul 22, 2026 | Silber JeffreySVP, CMO, Head-Res&Drug | nothing paid | Award | 137,036 | Jul 22, 2026 |
| Silver RonaldPFO & PAO | Open-market sell | $578,063127,890 shares | Jul 9, 2026 | Silver RonaldPFO & PAO | $578,063 | Open-market sell | 127,890 | Jul 9, 2026 |